TITLE

INCREASED INCIDENCE AND SEVERITY OF RETINOPATHY OF PREMATURITY IN DEVELOPING NATIONS

AUTHOR(S)
Wagner, Rudolph S.
PUB. DATE
July 2003
SOURCE
Journal of Pediatric Ophthalmology & Strabismus;Jul/Aug2003, Vol. 40 Issue 4, p193
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses various reports published within the issue including the increased incidence and severity of retinopathy of prematurity in developing nations.
ACCESSION #
20084278

 

Related Articles

  • Early testing can catch ROP. Fraioli, Anthony // Ophthalmology Times;6/15/96, Vol. 21 Issue 18, p18 

    Features the Cryotherapy for Retinopathy of Prematurity Cooperative Group's reduction of the unfavorable outcomes associated with the testing of retinopathy of prematurity (ROP) in premature babies. Screening all at-risk babies; Tips for successfully examining the retinas of small premature...

  • Increased foveal thickness may be observed in preterm infants born before 28 weeks of gestational age.  // Ocular Surgery News;8/25/2012, Vol. 30 Issue 16, p12 

    No abstract available.

  • Eye on babies.  // Grand Rapids Parent Magazine;Dec96, Vol. 8 Issue 12, p8 

    Focuses on Retinopathy of Prematurity (ROP), premature retina of premature babies. Percentages of premature babies in the United States; Prevention for ROP; Organization which supports ROP.

  • Retinopathy of Prematurity--Word Search. Fraser, Deb // Neonatal Network;Nov/Dec2015, Vol. 34 Issue 6, p369 

    No abstract available.

  • No benefit found from early treatment of posterior ROP. You, Timothy // Ophthalmology Times;02/01/97, Vol. 22 Issue 3, p33 

    Reports on the results of a multicenter randomized trial focusing on the potential benefit of early treatment in posterior retinopathy of prematurity (ROP). Significance of the study in the understanding of the natural history and therapy for ROP.

  • RLF.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2047 

    A definition of the acronym "RLF" which refers to retrolental fibroplasia is presented.

  • Retinopathy of prematurity in practice. II: long-term results following treatment for threshold disease. Gnanaraj, L; Brennan, R; Cottrell, D G // Eye;Mar2003, Vol. 17 Issue 2, p189 

    Objective To determine the long-term outcome of treatment for threshold retinopathy of prematurity (ROP) in one UK unit. Methods A total of 35 infants diagnosed with threshold ROP were treated by a single ophthalmologist (DGC) between 1987 and 1998. The parents of the 29 surviving patients were...

  • The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes. Stitt, Alan; Gardiner, Thomas A.; Anderson, Nathan L.; Canning, Paul; Frizzell, Norma; Duffy, Noel; Boyle, Cliona; Januszewski, Andrzej S.; Chachich, Mark; Baynes, John W.; Thorpe, Suzanne R. // Diabetes;Sep2002, Vol. 51 Issue 9, p2826 

    We examined the ability of pyridoxamine (PM), an inhibitor of formation of advanced glycation end products (AGEs) and lipoxidation end products (ALEs), to protect against diabetes-induced retinal vascular lesions. The effects of PM were compared with the antioxidants vitamin E (VE) and...

  • Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes. Chaturvedi, Nish; Sjoelie, Anne-Katrin; Porta, Massimo; Aldington, Steven J.; Fuller, John H.; Songini, Marco; Kohner, Eva M. // Diabetes Care;Feb2001, Vol. 24 Issue 2, p284 

    Presents a study which determined the incidence of retinopathy and the relative importance of its risk factors in type 1 diabetes. Information on retinopathy; Research design and methodology; Results and conclusions.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics